Claas Röhl

431 total citations
14 papers, 48 citations indexed

About

Claas Röhl is a scholar working on Neurology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Claas Röhl has authored 14 papers receiving a total of 48 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 4 papers in Pathology and Forensic Medicine and 3 papers in Epidemiology. Recurrent topics in Claas Röhl's work include Neurofibromatosis and Schwannoma Cases (7 papers), Meningioma and schwannoma management (3 papers) and Statistical Methods in Clinical Trials (2 papers). Claas Röhl is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (7 papers), Meningioma and schwannoma management (3 papers) and Statistical Methods in Clinical Trials (2 papers). Claas Röhl collaborates with scholars based in Austria, United States and Netherlands. Claas Röhl's co-authors include Nicoline Hoogerbrugge, N.A. Geverink, Janet R. Vos, Scott R. Plotkin, Daniel Berg, Dominique C. Pichard, Jaishri O. Blakeley, Vanessa L. Merker, Ana‐Maria Vranceanu and Pamela L. Wolters and has published in prestigious journals such as Neurology, Annals of the Rheumatic Diseases and American Journal of Medical Genetics Part A.

In The Last Decade

Claas Röhl

10 papers receiving 48 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claas Röhl Austria 5 25 10 9 9 7 14 48
Keerthika Sampat United Kingdom 6 12 0.5× 4 0.4× 6 0.7× 4 0.4× 6 62
Anna Sobala Austria 3 8 0.3× 7 0.7× 5 0.6× 8 0.9× 3 48
Nicole Scobie France 7 18 0.7× 5 0.5× 3 0.3× 1 0.1× 7 1.0× 10 69
Eleonóra Klímová Slovakia 6 15 0.6× 8 0.8× 60 6.7× 20 2.2× 4 0.6× 17 98
Nicholas Whipple United States 4 17 0.7× 13 1.3× 2 0.2× 3 0.3× 9 52
Guillaume Vial France 5 4 0.2× 6 0.6× 4 0.4× 2 0.2× 3 0.4× 16 50
Selim Jennane Morocco 5 5 0.2× 6 0.6× 15 1.7× 5 0.6× 16 40
Palma Solano‐Páez Spain 4 11 0.4× 4 0.4× 2 0.2× 2 0.2× 8 39
Damien Bodet France 4 12 0.5× 2 0.2× 15 1.7× 18 2.0× 6 44
Ankit Singh Tomar India 6 8 0.3× 10 1.0× 4 0.4× 4 0.4× 1 0.1× 12 67

Countries citing papers authored by Claas Röhl

Since Specialization
Citations

This map shows the geographic impact of Claas Röhl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claas Röhl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claas Röhl more than expected).

Fields of papers citing papers by Claas Röhl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claas Röhl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claas Röhl. The network helps show where Claas Röhl may publish in the future.

Co-authorship network of co-authors of Claas Röhl

This figure shows the co-authorship network connecting the top 25 collaborators of Claas Röhl. A scholar is included among the top collaborators of Claas Röhl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claas Röhl. Claas Röhl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Azizi, Amedeo A., Christian Rauscher, Robert Birnbacher, et al.. (2024). Publisher Erratum: Neurofibromatose Typ 1: Vorsorgebogen für Kinder und Jugendliche in Österreich. Monatsschrift Kinderheilkunde. 174(S1). 61–62. 1 indexed citations
3.
Azizi, Amedeo A., et al.. (2024). Neurofibromatosis type 1 adult surveillance form for Austria. Wiener klinische Wochenschrift. 137(15-16). 487–494. 1 indexed citations
4.
5.
Azizi, Amedeo A., Christian Rauscher, Robert Birnbacher, et al.. (2024). Neurofibromatose Typ 1: Vorsorgebogen für Kinder und Jugendliche in Österreich. Monatsschrift Kinderheilkunde. 173(8). 662–669. 1 indexed citations
6.
Cannon, Ashley, Kavita Y. Sarin, Andrea Petersen, et al.. (2023). Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials. Clinical Trials. 21(1). 67–72.
7.
Merker, Vanessa L., Pamela L. Wolters, Frank D. Buono, et al.. (2023). Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials. Clinical Trials. 21(1). 6–17. 2 indexed citations
8.
Wolters, Pamela L., Staci Martin, Daniel Berg, et al.. (2023). Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey. Clinical Trials. 21(1). 73–84. 3 indexed citations
9.
Jarke, Hannes, et al.. (2023). Patient and community engagement in clinical platform trials. Open Research Europe. 3. 74–74.
10.
Klimek, Peter, Martin Brunner, Gerhard Garhöfer, et al.. (2022). Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus. JMIR Medical Informatics. 10(6). e34204–e34204. 5 indexed citations
11.
Cannon, Ashley, Dominique C. Pichard, Pamela L. Wolters, et al.. (2021). Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas. Neurology. 97(7_Supplement_1). S15–S24. 8 indexed citations
12.
Wolters, Pamela L., Staci Martin, Daniel Berg, et al.. (2021). Impact of the coronavirus pandemic on mental health and health care in adults with neurofibromatosis: Patient perspectives from an online survey. American Journal of Medical Genetics Part A. 188(1). 71–82. 7 indexed citations
13.
Vos, Janet R., et al.. (2018). Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes. Familial Cancer. 18(2). 281–284. 15 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keerthika Sampat Breakdown of academic impact, for papers by Anna Sobala Breakdown of academic impact, for papers by Nicole Scobie Breakdown of academic impact, for papers by Eleonóra Klímová Breakdown of academic impact, for papers by Nicholas Whipple Breakdown of academic impact, for papers by Guillaume Vial Breakdown of academic impact, for papers by Selim Jennane Breakdown of academic impact, for papers by Palma Solano‐Páez Breakdown of academic impact, for papers by Damien Bodet Breakdown of academic impact, for papers by Ankit Singh Tomar
Rankless by CCL
2026